As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

CytomX Therapeutics, Inc. is downgraded to Hold ahead of key CX-2051 Phase 1 expansion data in 1Q26. Learn more about CTMX ...

Frits Stulp, Implement Consulting, says AI and global collaboration are key to addressing patent cliffs and accelerating ...

Geron stock struggles as RYTELO faces niche demand, high discontinuation, and major cost cuts. Click here to read my most ...

It seems that every day brings a new artificial intelligence solution to health care, with providers able to automate myriad ...

Healthcare AI moved beyond the pilot phase in 2025. From saving hundreds of lives to reducing costs by $20 million to more than $100 million annually, health systems started experiencing measurable ...

Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

West Texas A&M University is offering students access to free AI education and job training programs through Grow with Google. WT joined the Grow with Google pilot program with universities around The ...

Objective To determine whether a full-scale randomised control trial (RCT) assessing the efficacy and cost-effectiveness of a ...

CHS is tackling debt and redefining itself as a healthcare company by focusing on quality, operational efficiency, ...

The past few decades have seen a dramatic shift in how human disorders can be treated. Growing knowledge of the molecular dynamics underlying physiological processes and technological advances are ...

Objective Chronic kidney disease (CKD) arises due to uncontrolled hypertension (HTN). HTN significantly increases the risk of complications in vital organs, mainly the kidneys. If hypertensive ...